Loading...
XNAS:RDHL
RedHill Biopharma shares are trading higher after the company announced a $10.5 million judgment victory in the New York Supreme Court against Kukbo Co. Ltd, clearing the way for enforcement and asset protection measures.
RedHill Biopharma shares are trading higher after the company won a New York Supreme Court appeal, upholding a $10 million summary judgment against Kukbo.
RedHill Biopharma shares are trading higher after receiving positive FDA feedback on the pathway to approval for their groundbreaking RHB-204 program targeting Crohn's disease, signaling potential commercial opportunities in the expanding market.
RedHill Biopharma shares are trading lower after receiving a Nasdaq notification regarding non-compliance with stockholders' equity requirements.